Method of using a key to secure components of a drug delivery system during assembly

Information

  • Patent Grant
  • 10716890
  • Patent Number
    10,716,890
  • Date Filed
    Thursday, November 3, 2016
    8 years ago
  • Date Issued
    Tuesday, July 21, 2020
    4 years ago
Abstract
A method of securing an assembly of a drug delivery system, comprising: configuring at least a first component and a second component of the assembly in a closed configuration ready for placement into the drug delivery system; installing an assembly key including a locking element on the assembly to secure the assembly in said configuration; and, transporting the assembly with the assembly key installed.
Description
BACKGROUND OF THE INVENTION

The present invention, in some embodiments thereof, relates to drug delivery systems and, more particularly, but not exclusively, to apparatuses and methods for securing components of a drug delivery system during assembly and/or transport.


Failure to use a delivery device or system, such as an insulin pen or auto-injector, correctly could result in a life or death emergency, or impact a patient's or caregiver's ability to manage a medical condition effectively. For the pharmaceutical manufacturer, such a failure could result in a massive backlash that may cause loss of market share, costly product recalls or worse.


The primary goal of any drug delivery system is to ensure that a patient receives a proper dose of a prescribed drug. In years past, if a device failed or was used incorrectly, patient or caregiver error was most often the culprit. While providing detailed instructions is important for any pharmaceutical manufacturer, failure to follow directions is no longer a viable excuse when a patient or caregiver is unable to operate a device or delivery system successfully.


Effective drug therapy and treatment typically involves more than simply having an effective molecule. Rather, it is the combination of a safe drug within a suitable container and/or delivery system.


Historically, pharmaceutical manufacturers have focused, and rightly so, on the efficacy and safety of the drug product. However, if the drug is to achieve its therapeutic objective, then its primary container and delivery system must be both compatible with the drug and stable over time, as well as foster adherence from the patient. A drug can only truly have the desired patient benefit if it is taken as prescribed, delivered effectively (often by a patient or caregiver), and maintains performance over time.


Today's injectable therapies can take many forms. Liquid drugs may use a traditional syringe and vial; a prefilled syringe; or a delivery system such as an auto-injector, pen device or patch injector. Lyophilized drug products (requiring reconstitution with water for injection) may use a kit containing a transfer device, syringe or needle, and containers of the drug and water.


The container format itself also should be considered. Vials may be used for initial use, but a syringe or cartridge system may provide the best solution for the patient when the system reaches the market. Once the primary container has been selected, efforts must be made to ensure that it works with the delivery system. Dimensional tolerances and functionality should be tested to ensure proper activation and gliding forces.


Recognizing how the patient or caregiver interacts with the delivery system is essential to ensuring success in the market. Even the most innovative drug can provide the appropriate therapeutic benefit to the patient only if it can be delivered effectively and the patient adheres to the treatment regimen. Patients or caregivers may choose one product over another based on dose frequency, pain associated with dosing, or ease of use or mobility of the delivery system. Simply put, packaging can differentiate a product's market acceptance.


One frequent ease of use issue that is encountered by users of drug delivery systems, for example patch injectors like the SmartDoseĀ® Electronic Patch Injector System offered by Medimop Medical Projects Ltd., a subsidiary of West Pharmaceutical Services, Inc., is movement of the operative parts during transport. For example, vibrations during transport may cause movements of screws causing a telescoping assembly (TSA) of the delivery system to extend. As result, when a cartridge containing the unintentionally extended telescoping assembly is inserted by the user, it may be difficult to close the door of the delivery system. Some users may interpret this as a malfunction and elect not use the unit.


International Patent Application Publication No. WO/2011/090956, the disclosure of which is incorporated herein by reference, describes a cartridge interface assembly characterized by a driving plunger including an outer shaft, and a driver including an inner shaft movable telescopically with respect to the outer shaft, wherein rotation of the driver causes the driving plunger to advance in a direction away from the driver. When the cartridge interface assembly is inserted in a cartridge in which a plunger is slidingly disposed, rotation of the driver causes the driving plunger to advance distally in the cartridge until abutting against the plunger. The shafts may tend to unscrew during transportation and handling before assembly, with the result that the position, which is the desirable position for assembly with the cartridge plunger, is not maintained. On the other hand, if the driver is tightened too much against the body of assembly in an effort to maintain the closed position of this can increase the torque used by the motor to overcome the tight connection in order to start turning the driver, thereby overburdening the motor. To solve this double problem (possible opening of telescoping shafts or the driver being tightened too much), a locking assembly is provided


BRIEF SUMMARY OF THE INVENTION

An aspect of some embodiments of the invention relates to an assembly key used for securing a telescoping assembly of a drug delivery system during transport. In some embodiments of the invention, the drug delivery system is a patch injector.


In an exemplary embodiment of the invention, the assembly key is provided with a locking bit which is adapted to interface with at least one component of the telescoping assembly. In an embodiment of the invention, the locking bit is inserted into a key slot located on a pushing nut screw of the telescoping assembly. In some embodiments of the invention, the locking bit first passes through a bit aperture of a cartridge gear of the telescoping assembly, thereby linking the cartridge gear and pushing nut screw together, but also substantially or entirely preventing the turning of the telescoping assembly, for example as a result of vibrations during transport.


In some embodiments of the invention, the assembly key is removably attached to the cartridge gear. At least one clip is provided to the assembly key which snaps into at least one counterpart clip aperture located on the cartridge gear.


In some embodiments of the invention, the pushing nut screw is at least partially deformed in order to retain a mid screw located within the pushing nut screw. In an embodiment of the invention, retention of the mid screw substantially prevents rotation of the telescoping assembly, and thereby effectuates substantial stoppage of unintended extension of the telescoping assembly.


An aspect of some embodiments of the invention relates to a method for assembling a telescoping assembly and securing it for transport. In an embodiment of the invention, a mid screw of the telescoping assembly is threaded onto an internal screw of the telescoping assembly. A cartridge gear of the telescoping assembly is applied onto the internal screw from the same end of the internal screw that the mid screw was threaded, in an embodiment of the invention. In an embodiment of the invention, the three assembled components (the mid screw, the internal screw and the cartridge gear) are threaded into a pushing nut screw of the telescoping assembly, which is already attached to a pushing nut cover of the telescoping assembly.


In some embodiments of the invention, the three assembled components (the mid screw, the internal screw and the cartridge gear) are screwed into the pushing nut screw so that a bit aperture located on the cartridge gear is aligned with a key slot on the pushing nut screw.


An assembly key is installed onto the completed telescoping assembly by inserting a locking bit located on the assembly key into the bit aperture and further, into the key slot.


In some embodiments of the invention, at least one clip provided to the assembly key is inserted through at least one counterpart clip aperture located on the cartridge gear to removably attach the assembly key to the telescoping assembly.


In an embodiment of the invention, the locking bit inserted into the locking hit aperture and into the key slot substantially prevents rotation of the pushing nut screw and/or the unintended extension of telescoping assembly as a result of vibrations during transport.


In an embodiment of the invention, the assembly key is removed from the telescoping assembly after transport to enable normal operation of the telescoping assembly and the drug delivery system.


In an embodiment of the invention, the assembly key is economically manufactured and/or is constructed of inexpensive materials. Optionally, the assembly key is disposable and is disposed of after use.


An aspect of some embodiments of the invention relates to an alternative method for assembling a telescoping assembly and securing it for transport. In an embodiment of the invention, a pushing nut screw of the telescoping assembly is attached to a pushing nut cover of the telescoping assembly. A mid screw of the telescoping assembly is threaded into the pushing nut screw. In an embodiment of the invention, an internal screw is threaded into the mid screw. A cartridge gear of the telescoping assembly is installed at the end of the internal screw opposite the pushing nut cover.


In an embodiment of the invention, an assembly key is installed onto the completed telescoping assembly by inserting a locking bit of the assembly key into a bit aperture located on the cartridge gear and further, into a key slot of the pushing nut screw.


In some embodiments of the invention, at least one clip provided to the assembly key is inserted through at least one counterpart clip aperture located on the cartridge gear to removably attach the assembly key to the telescoping assembly.


In an embodiment of the invention, the locking bit inserted into the locking bit aperture and into the key slot substantially prevents rotation of the pushing nut screw and/or the unintended extension of telescoping assembly as a result of vibrations during transport.


In an embodiment of the invention, the assembly key is removed from the telescoping assembly after transport to enable normal operation of the telescoping assembly and the drug delivery system.


In an embodiment of the invention, the pushing nut screw is at least partially deformed near or at the end opposite the pushing nut cover to create a stop for the mid screw, creating an additional means for securing the telescoping assembly during transport. Optionally, the stop is created by driving a shot pin into the pushing nut screw 104, possibly heated or ultrasonic.


An aspect of some embodiments of the invention relates to a method for using an assembly key to secure a telescoping assembly of a drug delivery system. In an embodiment of the invention, the assembly key is removably attached to at least one component of the telescoping assembly by inserting a locking bit of the assembly key into a bit aperture of a cartridge gear of the telescoping assembly and further, into a key slot of a pushing nut screw of the telescoping assembly.


In some embodiments of the invention, at least one clip provided to the assembly key is inserted through at least one counterpart clip aperture located on the cartridge gear to removably attach the assembly key to the telescoping assembly.


In an embodiment of the invention, the locking bit inserted into the locking bit aperture and into the key slot substantially prevents rotation of the pushing nut screw and/or the unintended extension of telescoping assembly as a result of vibrations during transport.


In an embodiment of the invention, the assembly key is removed from the telescoping assembly after transport to enable normal operation of the telescoping assembly and the drug delivery system.


An aspect of some embodiments of the current invention relates to an assembly key that may secure a telescoping assembly in a desired configuration and/or assist assembly of the telescoping assembly into a medicine dispensing device. For example, a telescoping assembly may be delivered to a drug supplier for assembly into a syringe containing a drug. The drug supplier may need to orient the telescoping assembly and/or insert a portion of the assembly into a syringe and/or connect the telescoping assembly to a plunger inside the syringe. An assembly key may optionally have markings and/or a geometry to assist orientation of the telescoping assembly. The assembly key may optionally secure the telescoping assembly in the proper configuration for assembly to the syringe. The assembly key may optionally provide a gripping surface for attaching the telescoping assembly to the plunger of the syringe. Optionally, the plunger is considered to be a component of the telescoping assembly.


An aspect of some embodiments of the current invention relates to an assembly key that may secure a telescoping assembly in a desired configuration for deployment by an end user. An end user may optionally insert a cartridge into a drug delivery device (for example an infuser and/or a patch injector) and/or administer the drug. An assembly key may optionally include markings and/or a geometry to assist orientation of the telescoping assembly. The assembly key may optionally secure the telescoping assembly in the proper configuration for insertion into a delivery device and/or drug delivery. In some embodiments, the assembly key may be removed before the beginning of drug delivery. The assembly key may optionally include features that assist simple, intuitive removal of the key before use.


There is provided in accordance with an exemplary embodiment of the invention, a method of securing an assembly of a drug delivery system, comprising: configuring at least a first component and a second component of the assembly in a closed configuration ready for placement into the drug delivery system; installing an assembly key including a locking element on the assembly to secure the assembly in the configuration; and, transporting the assembly with the assembly key installed.


In an embodiment of the invention, the method further comprises employing the assembly key to facilitate assembly of the assembly during manufacture.


In an embodiment of the invention, the transporting is to an end user.


In an embodiment of the invention, the method further comprises removing the assembly key after transporting.


In an embodiment of the invention, the method further comprises disposing of the assembly key after removing.


In an embodiment of the invention, the removing is by the end user.


In an embodiment of the invention, the securing includes preventing relative movement of at least two components of the assembly.


In an embodiment of the invention, installing the assembly key includes inserting the locking element of the assembly key through a bit aperture of a first component of the assembly and into a slot, aligned with the bit aperture, of a second component of the assembly, thereby preventing relative movement of the first component and the second component.


In an embodiment of the invention, installing the assembly key includes inserting the locking element of the assembly key through a key aperture of a first component of the assembly and into a key slot, aligned with the key aperture, of a second component of the assembly, thereby preventing relative movement of the first component and the second component.


In an embodiment of the invention, installing comprises removably inserting at least one clip into a first component of the assembly.


In an embodiment of the invention, the at least one clip is installed through the top of the first component.


In an embodiment of the invention, the at least one clip is installed on the outside of the first component.


In an embodiment of the invention, a driver component is the first component and an actuating component is the second component.


In an embodiment of the invention, the driver component includes a gear.


In an embodiment of the invention, wherein the actuating component includes a pushing nut cover configured for pushing a plunger of a syringe.


In an embodiment of the invention, the method further comprises providing the assembly key with a distinguishing feature to make the assembly key easier to identify for removing.


In an embodiment of the invention, the method further comprises using the assembly key as a mechanical linkage between the assembly and an assembly machine during manufacture of the assembly key prior to transporting.


In an embodiment of the invention, the method further comprises using the assembly key to sense the orientation of the assembly during manufacturing.


In an embodiment of the invention, the method further comprises using the assembly key to screw the assembly into a plunger of the drug delivery system.


In an embodiment of the invention, installing includes passing a locking bit of the assembly key through a bit aperture in a first of the at least two components and into a key slot of a second of the at least two components.


There is provided in accordance with an exemplary embodiment of the invention, a system for preventing unintended linear extension of an assembly of a drug delivery system during transport, comprising: an assembly including at least a first component and a second component in a closed configuration; and, an assembly key including a locking element removably installed on the closed assembly, wherein the locking element of the assembly key prevents motion of at least the first component and the second component with respect to each other, thereby preventing extension of the closed assembly during transport.


In an embodiment of the invention, at least the first component and the second component are interconnected by a screw thread and wherein relative rotation of the first and second component causes extension of the assembly.


In an embodiment of the invention, the assembly key includes at least one locking element configured to interplay with at least the first component and the second component such that the two components are prevented from rotating with respect to each other, thereby preventing linear extension of the assembly.


In an embodiment of the invention, the first component of the assembly includes an actuating component for pushing a plunger of the drug delivery system.


In an embodiment of the invention, the first component is provided with a key slot adapted as a counterpart to the locking element.


In an embodiment of the invention, the second component includes a driver component.


In an embodiment of the invention, the second component includes a gear.


In an embodiment of the invention, the second component is provided with a key aperture adapted to the locking element therethrough.


In an embodiment of the invention, the key aperture on the second component aligns with a key slot on the first component to pass the locking element through the first and second components together.


In an embodiment of the invention, the assembly key further comprises at least one clip for removably attaching the assembly key to at least one component of the assembly.


In an embodiment of the invention, the system further comprises at least one clip aperture provided to the at least one component of the assembly configured as a counterpart to the at least one clip.


Unless otherwise defined, all technical and/or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and/or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example, are not to scale, and are for purposes of illustrative discussion of embodiments of the invention. In this regard, the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.


In the drawings:



FIG. 1 is a block diagram illustrating a system for preventing unintended extension of a telescoping assembly of a drug delivery system, in accordance with an exemplary embodiment of the invention;



FIG. 2 is an exploded perspective view of a telescoping assembly of a drug delivery system, in accordance with an exemplary embodiment of the invention;



FIG. 3 is a perspective view of the telescoping assembly of a drug delivery system with an assembly key of FIG. 2 in a closed configuration, in accordance with an exemplary embodiment of the invention;



FIG. 4 is a perspective, cross-sectional view of the closed telescoping assembly with assembly key of FIG. 3, in accordance with an exemplary embodiment of the invention;



FIG. 5 is a perspective view of the closed telescoping assembly of FIG. 3 showing the top of the cartridge gear with the assembly key removed, in accordance with an exemplary embodiment of the invention;



FIGS. 6A-6C are perspective views of the assembly key, in accordance with an exemplary embodiment of the invention;



FIG. 7A is a perspective view of a telescoping assembly showing a key slot in a component of the assembly which acts as a counterpart to the assembly key, in accordance with an exemplary embodiment of the invention;



FIG. 7B is a close-up, perspective view of the assembly key engaged with the key slot, in accordance with an exemplary embodiment of the invention;



FIG. 8 is a flowchart of a method for assembling a telescoping assembly of a drug delivery system while also securing it for transport, in accordance with an exemplary embodiment of the invention;



FIG. 9 is a flowchart of an alternative method for assembling a telescoping assembly of a drug delivery system while also securing it for transport, in accordance with an exemplary embodiment of the invention;



FIG. 10 is a flowchart of a method for using an assembly key to secure a telescoping assembly of a drug delivery system, in accordance with an exemplary embodiment of the invention;



FIG. 11A is a perspective view of an alternative telescoping assembly showing a key slot in a component of the assembly which acts as a counterpart to an alternative assembly key, in accordance with an exemplary embodiment of the invention;



FIG. 11B is a perspective view of the assembled, closed alternative telescoping assembly of FIG. 11A, in accordance with an exemplary embodiment of the invention;



FIG. 11C is a cross-sectional view of the alternative telescoping assembly with assembly key of FIG. 11B, in accordance with an exemplary embodiment of the invention; and,



FIGS. 12A-12C are perspective views of the alternative assembly key, in accordance with an exemplary embodiment of the invention.





DETAILED DESCRIPTION OF THE INVENTION

The present invention, in some embodiments thereof, relates to drug delivery systems and, more particularly, but not exclusively, to apparatuses and methods for securing components of a drug delivery system during transport.


Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth in the following description and/or illustrated in the drawings and/or the exemplary embodiments. The invention is capable of other embodiments or of being practiced or carried out in various ways.


Referring now to the drawings, FIG. 1 is a block diagram illustrating a system 100 for preventing unintended movement of a telescoping assembly 101 of a drug delivery system, in accordance with an exemplary embodiment of the invention. In an embodiment of the invention, the system is comprised of the telescoping assembly 101, a plunger 112 advanced by the telescoping assembly 101, and an assembly key 150. In an embodiment of the invention, the assembly key 150 is a separate component from the telescoping assembly 101, provided with latches and/or clips to removably attach it to at least one component of the assembly and which substantially retains the telescoping assembly 101 in a set configuration by preventing the linear movement of at least a first component 102 of the telescoping assembly 101 with respect to at least a second component 104 of the telescoping assembly 101. In an embodiment of the invention, the set configuration is a closed configuration.


In some embodiments of the invention, extension of the telescoping assembly 101 is achieved by rotation of at least one of the components of the assembly 101. For example, the assembly key 150 substantially prevents rotation of the assembly 101 by interlocking at least two components of the assembly 101, which in some embodiments has at least four components, as shown in FIGS. 2-4, to prevent their rotation with respect to each other.


In some embodiments of the invention, the drug delivery system is a patch injector system. In some embodiments of the invention, the telescoping assembly 101 is an operative component of a cartridge of a patch injector system, wherein the disposable and/or interchangeable cartridge contains a pre-measured dose of a drug to be administered to a patient using the drug delivery system.


It should be understood that in order to utilize a smaller, more economical motor, the force used to screw the telescoping assembly 101 in order to extend and retract it may optionally be minimized with low friction threading. This low friction threading allows for easier movement using the motor, but it is also what allows for easy unintended movement of the assembly 101 as a result of vibrations, for example during transport.



FIG. 2 illustrates an exploded perspective view of a telescoping assembly 101 of a drug delivery system, in accordance with an exemplary embodiment of the invention. In an embodiment of the invention, telescoping assembly 101 is comprised of at least one second component/driver component, for example a cartridge gear 202, and/or at least one first component—that is, at least one external screw, for example a pushing nut screw 204, and/or at least one mid screw 206, and/or an internal screw 208 and/or a actuating component, for example a pushing nut cover 210 (shown in FIG. 2 pre-attached to pushing nut screw 204) for pushing a syringe plunger 112, shown in phantom in FIGS. 2-4. Telescoping assembly 101 includes three elongated threaded elements (pushing nut screw 204, mid screw 206 and internal screw 208) which move longitudinally with respect to one another to telescope (extend or close) the assembly, in an embodiment of the invention. The elongated elements may be interconnected by screw threads which drive the longitudinal movement when the elongated elements are rotated relative to one another. Thus, as shown in FIGS. 2-4, each elongated threaded element (pushing nut screw 204, mid screw 206 and internal screw 208) is a component having screw threads: pushing nut screw 204 has internal screw threads 204a (FIG. 4); mid screw 206 has external screw threads 206a and internal screw threads 206b (FIGS. 2 and 4); and internal screw 208 has external screw threads 208a (FIG. 4). As shown in FIG. 4, pushing nut screw 204 is connected by screw threads 204a and 206a to mid screw 206, and internal screw 208 is interconnected by a screw threads 208a and 206b to mid screw 206, such that relative rotation of the first component of any two of the components with respect to a second component interconnected to the first component by a screw thread may cause extension of the telescoping assembly. Alternatively or additionally, a telescoping assembly may include two, four or more elongated elements that may move longitudinally with respect to each other and/or may be interconnected by screw threads and/or may be driven by relative rotation (for example, as shown in FIGS. 2-4, pushing nut screw 204, mid screw 206 and internal screw 208).


In an embodiment of the invention, an assembly key 150 is provided to the telescoping assembly 101 to secure the telescoping assembly 101 for transport and to optionally assist with assembly of the telescoping assembly 101 into a syringe and/or a plunger of the syringe. In some exemplary embodiments of the invention, the telescoping assembly 101 is configured to interplay with assembly key 150 to secure the telescoping assembly 101 for transport and/or assembly. For example, the telescoping assembly 101 is configured to be secured by inserting a locking element, for example, locking bit 602, shown and described in more detail with respect to FIGS. 6A-7B, of the assembly key 150 into at least one component of the telescoping assembly 101 thereby locking it to prevent unintended extension of the assembly 101, in an exemplary embodiment of the invention. In some embodiments of the invention, the at least one component of the assembly 101 into which the locking bit 602 is inserted is pushing nut screw 204.


In an embodiment of the invention, pushing nut cover 210 is attached to a plunger 112 (FIGS. 2-4) or stopper (not shown) in the cartridge of the patch injector. The plunger may provide a fluid proof seal against the liquid in the cartridge and which pushes the fluid out of the cartridge and into the patient when the telescoping assembly 101 extends and activates/instigates the pushing of the pushing nut cover 210.


In an embodiment of the invention, at least one component is manufactured from a medical grade polymer, for example Polybutylene Terephthalates (PBTs), Ticona Celanex 2402MT, Ticona Celanex 2405MT, Delrin 500AL and Delrin 500P. In some embodiments of the invention, at least one component is manufactured from a plurality of materials, for example the gears are Ticona Celanex 2402MT but the threads are Ticona Celanex 2405MT.


In an embodiment of the invention, the cartridge gear is approximately 12 mm in diameter. In some embodiments of the invention, the extension achieved by the telescoping assembly is approximately 11 mm (for example, the 11 mm is a total amount of extension of a plurality of individual components which extend and contribute to the total), although it should be understood that virtually any length of extension could be achieved by any number of components operatively connected to one another. In some embodiments of the invention, the assembly key diameter approximately matches that of the cartridge gear.



FIG. 3 is a perspective view of a telescoping assembly 101 with an assembly key 150 of a telescoping assembly 101 of a drug delivery system 100 that is closed (in a closed configuration) and locked by assembly key 150, in a typical secured configuration for transport and/or assembly and/or use in accordance with an exemplary embodiment of the invention. The telescoping assembly 101 is attachable to the plunger 112 (shown in phantom) via the pushing nut cover 210.



FIG. 4 is a perspective, cross-sectional view of the telescoping assembly 101 of FIG. 3 in a closed configuration, in accordance with an exemplary embodiment of the invention. In the example of FIG. 3, assembly key 150 is locked to cartridge gear 202 and/or locking bit 602 of the assembly key 150 is shown interfacing with the pushing nut screw 204 in a closed configuration. In an embodiment of the invention, assembly key prevents the turning of the pushing nut screw 204 with respect to cartridge gear 202, thereby preventing substantially or entirely the unintended extension of the telescoping assembly. A handle on the proximal end of assembly key 150 may provide a gripping point and/or locking bit 602 may provide a torque point for twisting pushing nut screw 204 and/or pushing nut cover 210 For example, nut cover 210 may be inserted into a syringe and assembly key 150 may be used to twist pushing nut cover 210, screwing it into the plunger 112 (shown in phantom).



FIG. 5 is a perspective view of the telescoping assembly 101 of FIG. 3 in a closed configuration showing the top of the cartridge gear 202 with the assembly key 150 removed, in accordance with an exemplary embodiment of the invention. In some embodiments of the invention, in the closed configuration shown, locking bit 602 is inserted through a bit aperture 502 in the cartridge gear 202 before it engages with a slot in the pushing nut screw 204. The assembly key 150 is provided with at least one clip 604, shown and described in more detail in FIGS. 6A-6C, which is removably attached to telescoping assembly 101 by inserting the at least one clip 604 through at least one counterpart clip aperture 504 located on the cartridge gear 202, in some embodiments of the invention. Additionally or alternatively, clip 604 may serve as a locking element, for example locking assembly key 150 to cartridge gear 202 and/or pushing nut screw 204. Additional details are shown in FIG. 4, wherein the at least one clip 604 is shown passing through a clip aperture 504 and through cartridge gear 202, in an embodiment of the invention.



FIGS. 6A-6C are perspective views of the assembly key 150, in accordance with an exemplary embodiment of the invention. Shown in more detail in the various views are the locking bit 602 and the at least one clip 604.



FIG. 7A is a perspective view of a telescoping assembly 101 showing a key slot 702 in a component of the assembly 101 which acts as a counterpart to the assembly key 150, in accordance with an exemplary embodiment of the invention. In some embodiments of the invention, the key slot 702 is located on the assembly key 150 key side of the pushing nut screw 204. In some embodiments of the invention, the key slot 702 aligns with the bit aperture 502 of the cartridge gear 202 (not shown in FIGS. 7A-7B, but shown in FIG. 5) whereby the locking bit 602 can be inserted through the bit aperture 502 and into the key slot 702.



FIG. 7B is a close-up, perspective view of the locking bit 602 of the assembly key 150 engaged with the key slot 702, in accordance with an exemplary embodiment of the invention. FIG. 7B does not show the cartridge gear 202 to make this configuration more visible, which in an embodiment of the invention would nominally surround the viewable portion of the pushing nut screw 204 and locking bit 602 in this Figure.



FIG. 8 is a flowchart of a method for configuring a telescoping assembly 101 of a drug delivery system and/or securing it for assembly and/or transport and/or deployment, in accordance with an exemplary embodiment of the invention. In an embodiment of the invention, the mid screw 206 is threaded (804) onto the internal screw 208 so that the threads on the exterior circumference of the mid screw are positioned substantially towards the pushing nut screw cover 210. The cartridge gear 202 is applied (806) onto the internal screw 208 at the end opposite the pushing nut cover 210, in an embodiment of the invention. In an embodiment of the invention, the three components 202, 206, 208 are threaded (808) into the pushing nut screw 204 by engaging the threads on the exterior circumference of the mid screw 206 with threads located on the inner circumference of the pushing nut screw 204, which is already attached (802) to the pushing nut cover 210. In an embodiment of the invention, the three components are screwed into the pushing nut screw 204 so that the bit aperture 502 located on the cartridge gear 202 is aligned (810) with the key slot 702 on the pushing nut screw 204.


The assembly key 150 is installed (812) onto the telescoping assembly 101 by inserting the locking bit 602 into the bit aperture 502 and further, into the key slot 702. Additionally and concurrently, the at least one clip 604 is inserted through the at least one counterpart clip aperture 504 located on the cartridge gear 202 to removably attach the assembly key 150 to the telescoping assembly 101. In an embodiment of the invention, the locking bit 602 inserted into the locking bit aperture 502 and into the key slot 702 substantially prevents rotation of the pushing nut screw 204 with respect to the cartridge gear 202. Assembly key 150 may optionally supply a way of aligning and/or gripping pushing nut screw 204 and/or cartridge gear 202, Assembly key 150 may optionally prevent the unintended extension and/or closing of telescoping assembly 101.


In an embodiment of the invention, the assembly key 150 is removed (814) from the telescoping assembly 101 after transport to enable normal operation of the telescoping assembly 101 and the drug delivery system. Removal (814) of assembly key 150 may be by simple pulling away from the telescoping assembly. Simple removal (814) of assembly key may contribute to the ease of use of the device.



FIG. 9 is a flowchart of an alternative method for configuring a telescoping assembly 101 of a drug delivery system while also securing it for transport, in accordance with an exemplary embodiment of the invention. In an embodiment of the invention, pushing nut screw 204 is attached (902) to the pushing nut cover 210. The mid screw 206 is threaded (904) into the pushing nut screw 204 by engaging the threads on the exterior circumference of the mid screw 206 with threads on the interior circumference of the pushing nut screw 204. In an embodiment of the invention, the internal screw 208 is threaded (906) into the mid screw 206. The internal screw 208 is optionally over rotated to make installation of the cartridge gear 202 easier. In an embodiment of the invention, the cartridge gear 202 is installed (908) onto the inner screw aligning the bit aperture 502 of the cartridge gear 202 with the key slot 702 of the pushing nut screw 204 and, if the inner screw 208 was over rotated, the inner screw 208 is returned to a stop position.


In some embodiments of the invention, the pushing nut screw 204 is at least partially deformed (914) near or at the end opposite the pushing nut cover 210 to create (912) a stop for the mid screw 206. Optionally, the stop is created by driving a shot pin into the pushing nut screw 204, possibly heated or ultrasonic.



FIG. 10 is a flowchart illustration of a method for assembling and using a drug delivery system, in accordance with an exemplary embodiment of the invention. In an embodiment of the invention, the telescoping assembly is configured (1002) for use, for example as described in FIGS. 8 and/or 9. In an embodiment of the invention, the assembly key 150 is installed (1004) on the telescoping assembly 101, securing the assembly 101. For example, securing may include removably attaching the assembly key 150 to at least one component of the telescoping assembly 101. The telescoping assembly is now secured, preventing unintended extension, for assembly and/or transport and/or deployment.


In some embodiments, after telescoping assembly 101 is configured (1002) and secured (1004), it may be placed into a drug delivery system. Optionally, assembly key 150 assists attachment (1012) of the telescoping assembly 150 into the syringe. For example, pushing nut cover 210 may be attached to a plunger of a syringe. Assembly key, supply a convenient gripping point and/or alignment indication for a person and/or a machine to hold pushing nut cover 210 and/or to insert it into the syringe and/or to align threads of pushing nut cover 210 to threads in the plunger and/or to twist pushing nut cover 210 to screw it into the plunger.


In some embodiments, the syringe and/or the telescoping assembly 101 may be transported (1006) to the end user. The assembly key 150 may optionally be left on the telescoping assembly 101 during transport (1006). For example, the telescoping assembly 150 may prevent the telescoping assembly from moving out of its proper configuration for example due to vibrations during transport (1006).


In some embodiments, once the syringe and/or the telescoping assembly 101 reach the end user, the assembly key may be removed (1008) and/or the syringe and/or the telescoping assembly 101 may be deployed. For example deployment may include inserting the syringe and/or assembly 101 into a delivery device (for example a patch injector). Transporting (1006) the telescoping assembly 101 with the assembly key 150 may help prevent the telescoping assembly 101 from extending during transport (1006). Unwanted extension of the telescoping assembly beyond its closed configuration might, for example, make it difficult to fit the assembly 101 and/or the syringe/cartridge into the injector.


The delivery device may optionally restrain the syringe and/or the plunger and/or pushing nut cover 210 from rotating while rotating cartridge gear 202 causing the telescoping assembly 101 to extend, pushing the plunger into the syringe and/or delivering the drug. In some cases, transporting (1006) telescoping assembly 101 with the assembly key 150 attached (1004) may prevent telescoping assembly 101 from closing up too much during transport. Over closing of the telescoping assembly 101 may for example cause thread lock within the telescoping assembly 101 which could cause failure of the delivery system.


In an embodiment of the invention, the assembly key 150 and/or the entire drug delivery system is disposed of (1010). For example, the delivery key 150 and/or the telescoping assembly and/or the delivery device may be made of safe materials that may be disposed of (1010) in municipal garbage.


With respect to the assemblies and methods described herein it should be understood that in an exemplary embodiment of the invention, the assembly 101, which is secured for transport as described herein, remains in a closed configuration and does not unintentionally linearly extend as a result of vibrations during transport. In an embodiment of the invention, ā€œtransportā€ is to be understood as moving from the manufacturer, through the distribution chain, and ultimately to the consumer. In some embodiments, ā€œtransportā€ is a sub-set of the chain described above. For example, as applied to transport on a truck from a port of entry to a distribution center. In an embodiment of the invention, such as any of those described herein, the assembly key provides sufficient locking force to ensure compliance under the ASTM D4169 performance testing of shipping containers and systems standards for combined air and rail transport. In some embodiments of the invention, the assembly key prevents unintended linear extension of the assembly while being subjected to extended vibrations up to 300 Hz. Optionally, extended vibration time is for hours, days or even weeks, for example in the case of cargo shipping overseas. In some embodiments of the invention, the assembly key prevents unintended linear extension of the assembly while being subjected to shocks up to 300 m/s2.


The secured assembly 101 is placed into a drug delivery system, for example a patch injector like the SmartDoseĀ® Electronic Patch Injector System offered by Medimop Medical Projects Ltd., a subsidiary of West Pharmaceutical Services, Inc. after the removal of the assembly key 150, in accordance with an exemplary embodiment of the invention.



FIG. 11A is a perspective view of an alternative telescoping assembly 1101 showing at least one bit aperture 1102 in at least one component of the assembly which acts as a counterpart to at least one locking bit 1152 of an assembly key 1150, in accordance with an exemplary embodiment of the invention. In some embodiments of the invention, the bit aperture 1102 is located on the assembly key 150 key side of the cartridge gear 1104.



FIG. 11B is a perspective view of the assembled, closed alternative telescoping assembly 1101 of FIG. 11A, in accordance with an exemplary embodiment of the invention.



FIG. 11C is a cross-sectional view of the alternative telescoping assembly 1101 with assembly key 1150 of FIG. 11B, in accordance with an exemplary embodiment of the invention.


In some embodiments of the invention, the bit aperture 1102 of the cartridge gear 1104 aligns with a key slot 1108 of the pushing nut screw 1106, enabling the locking bit 1152 of the assembly key 1150 to be inserted through the bit aperture 1102 and into the key slot 1108 preventing movement of the cartridge gear 1104 relative to the pushing nut screw 1106. In an embodiment of the invention, prevention of movement between the cartridge gear 1104 relative to the pushing nut screw 1106 prevents rotation of the assembly 1101, thereby preventing unintended extension of the assembly 1101.


In an embodiment of the invention, assembly key 1150 has a pair of clips 1110 for removal of the assembly key 1150 from the telescoping assembly 1101. In an embodiment of the invention, the pair of clips 1110 are squeezed sufficiently to cause deformation of the assembly key 1150 and to release the assembly key 1150 from the bit aperture 1102 and the key slot 1108. The use of deformable clips 1110 may make removal of assembly key 1150 easier for a nervous end user who may be reluctant to use force to remove assembly key 150 and/or who may become nervous that he might have broken the telescoping assembly 101 when he feels a snap giving way upon removal of assembly key 150. In some embodiments, deformation is elastic. In some embodiments, deformation is plastic. In some embodiments, deformation is a combination of elastic and plastic.



FIGS. 12A-12C are perspective views of the alternative assembly key 1150, in accordance with an exemplary embodiment of the invention.


In an embodiment of the invention, the assembly key 150, 1150 uses the same interface to attach to the telescoping assembly 101, 1101 as an assembly machine used for assembling the components of the telescoping assembly 101, 1101. In some embodiments of the invention, assembly key 150, 1150 is used as a linkage between the assembly machine and the telescoping assembly 101, 1101 during manufacturing. In an embodiment of the invention, after the telescoping assembly 101, 1101 is assembled, it is attached to a plunger of the drug delivery system, optionally by screwing. In an embodiment of the invention, the assembly key 150, 1150 provides a handle for manual or automatic screwing of the pushing nut cover into the plunger without extending, collapsing, screwing and/or unscrewing the telescoping assembly 150, 1150.


In an embodiment of the invention, the assembly key 150, 1150, used as a link between the telescoping assembly and the assembly machine during manufacturing, helps the assembly machine recognize the orientation of the telescoping assembly 101, 1101 during assembly, which can be important for proper assembly of the telescoping assembly 101, 1101 and insertion of it into the plunger. In an embodiment of the invention, mechanical sensing of the telescoping assembly's orientation using the assembly key obviates the need for more expensive optical sensing equipment.


In some embodiments of the invention, assembly keys as described herein are provided with a distinguishing feature, for example color, for easy identification by the customer for easier removal and/or disposal.


It is expected that during the life of a patent maturing from this application many relevant securing technologies will be developed and the scope of the terms securing is intended to include all such new technologies a priori.


The terms ā€œcomprisesā€, ā€œcomprisingā€, ā€œincludesā€, ā€œincludingā€, ā€œhavingā€ and their conjugates mean ā€œincluding but not limited toā€.


The term ā€œconsisting ofā€ means ā€œincluding and limited toā€.


The term ā€œconsisting essentially ofā€ means that the composition, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.


As used herein, the singular form ā€œaā€, ā€œanā€ and ā€œtheā€ include plural references unless the context clearly dictates otherwise. For example, the term ā€œa compoundā€ or ā€œat least one compoundā€ may include a plurality of compounds, including mixtures thereof.


Throughout this application, various embodiments of this invention may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.


Whenever a numerical range is indicated herein, it is meant to include any cited numeral (fractional or integral) within the indicated range. The phrases ā€œranging/ranges betweenā€ a first indicate number and a second indicate number and ā€œranging/ranges fromā€ a first indicate number ā€œtoā€ a second indicate number are used herein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numerals therebetween.


It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.


Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.


All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting.

Claims
  • 1. A method of securing a telescoping assembly of a drug delivery system, comprising: configuring at least a pushing nut screw and an internal screw of the telescoping assembly in a closed configuration ready for placement into the drug delivery system, the pushing nut screw and the internal screw being interconnected by a screw thread such that relative rotation of the pushing nut screw with respect to the internal screw causes linear extension of the telescoping assembly;securing the telescoping assembly in said closed configuration with a locking element, wherein the locking element prevents relative rotation of at least the pushing nut screw and the internal screw with respect to each other in the closed configuration, thereby preventing linear extension of the telescoping assembly in the closed configuration; and,transporting the telescoping assembly secured with the locking element in the closed configuration.
  • 2. The method according to claim 1, wherein the transporting is to an end user.
  • 3. The method according to claim 1, further including inserting at least one clip into a clip aperture of the telescoping assembly so as to attach the locking element to the telescoping assembly.
  • 4. The method according to claim 3, wherein the at least one clip is inserted through a top of the pushing nut screw.
  • 5. The method according to claim 3, wherein the at least one clip is inserted on an outside of the pushing nut screw.
  • 6. The method according to claim 1, wherein the internal screw has a driver component applied thereto for rotating the internal screw.
  • 7. The method according to claim 6, wherein the driver component includes a gear.
  • 8. The method according to claim 1, wherein the telescoping assembly includes an actuating component configured for pushing a plunger of a syringe.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Divisional of U.S. patent application Ser. No. 13/874,121, filed on Apr. 30, 2013, currently pending, which is a Continuation-in-Part of U.S. patent application Ser. No. 12/244,666, filed on Oct. 2, 2008, now U.S. Pat. No. 9,173,997, issued Nov. 3, 2015, which claims priority to U.S. Provisional Patent Application No. 60/997,459, filed Oct. 2, 2007, the disclosures of all of which are incorporated by reference herein. This application is related to the U.S. patent application entitled DISENGAGEMENT RESISTANT TELESCOPING ASSEMBLY AND UNIDIRECTIONAL METHOD OF ASSEMBLY FOR SUCH, U.S. patent application Ser. No. 13/874,085, now U.S. Pat. No. 9,345,836, issued May 24, 2016, the disclosure of which is incorporated herein by reference.

US Referenced Citations (275)
Number Name Date Kind
232432 Allison Sep 1880 A
1795630 Wilson Mar 1931 A
2453590 Poux Nov 1948 A
2677373 Barradas May 1954 A
2702547 Glass Feb 1955 A
2860635 Wilburn Nov 1958 A
3203269 Perrine Aug 1965 A
3212685 Swan Oct 1965 A
3623474 Heilman et al. Nov 1971 A
3708945 Klettke Jan 1973 A
4189065 Herold Feb 1980 A
4195636 Behnke Apr 1980 A
4254768 Ty Mar 1981 A
4273122 Whitney et al. Jun 1981 A
4300554 Hessberg et al. Nov 1981 A
4324262 Hall Apr 1982 A
4403987 Gottinger Sep 1983 A
4425120 Sampson Jan 1984 A
4435173 Siposs et al. Mar 1984 A
4465478 Sabelman et al. Aug 1984 A
4502488 Degironimo Mar 1985 A
4504263 Steuer et al. Mar 1985 A
4549554 Markham Oct 1985 A
4564054 Gustavsson Jan 1986 A
4583974 Kokernak Apr 1986 A
4585439 Michel Apr 1986 A
4599082 Grimard Jul 1986 A
4664654 Strauss May 1987 A
4685903 Cable et al. Aug 1987 A
4695274 Fox Sep 1987 A
4698055 Sealfon Oct 1987 A
4702738 Spencer Oct 1987 A
4735311 Lowe et al. Apr 1988 A
4737144 Choksi Apr 1988 A
4772272 McFarland Sep 1988 A
4810215 Kaneko Mar 1989 A
4810249 Haber Mar 1989 A
4813426 Haber Mar 1989 A
4840185 Hernandez Jun 1989 A
4867743 Vaillancourt Sep 1989 A
4874383 McNaughton Oct 1989 A
4882575 Kawahara Nov 1989 A
4892521 Laico et al. Jan 1990 A
4897083 Martell Jan 1990 A
4900310 Ogle, II Feb 1990 A
4915702 Haber Apr 1990 A
4919596 Slate et al. Apr 1990 A
4923446 Page May 1990 A
4950241 Ranford Aug 1990 A
4964866 Szwarc Oct 1990 A
4994045 Ranford Feb 1991 A
4998924 Ranford Mar 1991 A
5019051 Hake May 1991 A
5051109 Simon Sep 1991 A
5088988 Talonn Feb 1992 A
5112317 Michel May 1992 A
5127910 Talonn Jul 1992 A
5147326 Talonn Sep 1992 A
5156599 Ranford Oct 1992 A
5190521 Hubbard et al. Mar 1993 A
5217437 Talonn Jun 1993 A
5267977 Feeney, Jr. Dec 1993 A
5300045 Plassche, Jr. Apr 1994 A
5318522 D'Antonio Jun 1994 A
5338311 Mahurkar Aug 1994 A
5383865 Michel Jan 1995 A
5415645 Friend May 1995 A
5478315 Brothers et al. Dec 1995 A
5501665 Jhuboo et al. Mar 1996 A
5562624 Righi Oct 1996 A
5609580 Kwiatkowski Mar 1997 A
5611785 Mito Mar 1997 A
5624400 Firth et al. Apr 1997 A
5637095 Nason et al. Jun 1997 A
5643218 Lynn et al. Jul 1997 A
5645530 Boukhny et al. Jul 1997 A
5647853 Feldmann et al. Jul 1997 A
5658256 Shields Aug 1997 A
5662678 Macklin Sep 1997 A
5697908 Imbert Dec 1997 A
5728075 Levander Mar 1998 A
5741275 Wyssmann Apr 1998 A
5766186 Faraz et al. Jun 1998 A
5810784 Tamaro Sep 1998 A
5830187 Kriesel et al. Nov 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5893842 Imbert Apr 1999 A
5894015 Rechtin Apr 1999 A
5919167 Mulhauser Jul 1999 A
5926596 Edwards Jul 1999 A
5944699 Barrelle et al. Aug 1999 A
5968011 Larsen et al. Oct 1999 A
5989221 Hjertman Nov 1999 A
5993423 Choi Nov 1999 A
6004296 Jansen Dec 1999 A
6033245 Yamkovoy Mar 2000 A
6045533 Kriesel et al. Apr 2000 A
6162197 Mohammad Dec 2000 A
6186982 Gross et al. Feb 2001 B1
6200296 Dibiasi et al. Mar 2001 B1
6248093 Moberg Jun 2001 B1
6270481 Mason et al. Aug 2001 B1
6277099 Strowe Aug 2001 B1
6287283 Ljunggreen et al. Sep 2001 B1
6302633 Poe Oct 2001 B1
6485461 Mason et al. Nov 2002 B1
6485465 Moberg Nov 2002 B2
6511336 Turek et al. Jan 2003 B1
6554800 Nezhadian et al. Apr 2003 B1
6565541 Sharp May 2003 B2
6595956 Gross et al. Jul 2003 B1
6656159 Flaherty Dec 2003 B2
6659980 Moberg et al. Dec 2003 B2
6699218 Flaherty et al. Mar 2004 B2
6722916 Buccinna et al. Apr 2004 B2
6743211 Prausnitz et al. Jun 2004 B1
6749587 Flaherty Jun 2004 B2
6752783 Hung Jun 2004 B2
6786890 Preuthun Sep 2004 B2
6800071 McConnell et al. Oct 2004 B1
6905298 Haring Jun 2005 B1
6960192 Flaherty et al. Nov 2005 B1
6997727 Legrady et al. Feb 2006 B1
7033338 Vilks Apr 2006 B2
7034223 Fan et al. Apr 2006 B2
7060054 Nissels Jun 2006 B2
7225694 Said Jun 2007 B2
7250037 Shermer et al. Jul 2007 B2
7291132 DeRuntz et al. Nov 2007 B2
7291159 Schmelzeisen-Redeker et al. Nov 2007 B2
7390312 Barrelle Jun 2008 B2
7407493 Cane' Aug 2008 B2
7442186 Blomquist Oct 2008 B2
7488181 van Haaster Feb 2009 B2
7501587 English Mar 2009 B2
7503786 Kato et al. Mar 2009 B2
7540858 DiBiasi Jun 2009 B2
7704088 Sakamoto Apr 2010 B2
7717903 Estes et al. May 2010 B2
7736344 Moberg et al. Jun 2010 B2
7766867 Lynch et al. Aug 2010 B2
7794426 Briones et al. Sep 2010 B2
7938803 Mernoe et al. May 2011 B2
7967795 Cabiri Jun 2011 B1
8057436 Causey et al. Nov 2011 B2
8062253 Nielsen et al. Nov 2011 B2
8105293 Pickhard Jan 2012 B2
8152779 Cabiri Apr 2012 B2
8157769 Cabiri Apr 2012 B2
8172591 Wertz May 2012 B2
8177749 Slate et al. May 2012 B2
8221356 Enggaard et al. Jul 2012 B2
8348898 Cabiri Jan 2013 B2
8425468 Weston Apr 2013 B2
8512295 Evans et al. Aug 2013 B2
8523803 Favreau Sep 2013 B1
8551046 Causey et al. Oct 2013 B2
8562364 Lin et al. Oct 2013 B2
8603026 Favreau Dec 2013 B2
8603027 Favreau Dec 2013 B2
8622966 Causey et al. Jan 2014 B2
8915882 Cabiri Dec 2014 B2
8979802 Woehr Mar 2015 B2
9011164 Filman et al. Apr 2015 B2
9072827 Cabiri Jul 2015 B2
9149575 Cabiri Oct 2015 B2
9173997 Gross et al. Nov 2015 B2
D747799 Norton et al. Jan 2016 S
9259532 Cabiri Feb 2016 B2
9314569 Causey et al. Apr 2016 B2
9345836 Cabiri et al. May 2016 B2
9350634 Fadell May 2016 B2
9393365 Cabiri Jul 2016 B2
9421323 Cabiri et al. Aug 2016 B2
9452261 Alon Sep 2016 B2
9522234 Cabiri Dec 2016 B2
9539388 Causey et al. Jan 2017 B2
9572926 Cabiri Feb 2017 B2
9656019 Cabiri May 2017 B2
9782545 Gross Oct 2017 B2
20010005781 Bergens Jun 2001 A1
20010018937 Nemoto Sep 2001 A1
20010025168 Gross et al. Sep 2001 A1
20010034502 Moberg et al. Oct 2001 A1
20010041869 Causey et al. Nov 2001 A1
20020016569 Critchlow et al. Feb 2002 A1
20020029018 Jeffrey Mar 2002 A1
20020151855 Douglas et al. Oct 2002 A1
20020169215 Meng Nov 2002 A1
20030009133 Ramey Jan 2003 A1
20030014018 Giambattista Jan 2003 A1
20030069518 Daley Apr 2003 A1
20030167039 Moberg Sep 2003 A1
20030216683 Shekalim Nov 2003 A1
20040000818 Preuthun et al. Jan 2004 A1
20040049160 Hsieh et al. Mar 2004 A1
20040082911 Tiu et al. Apr 2004 A1
20040092873 Moberg May 2004 A1
20040127857 Shemesh et al. Jul 2004 A1
20040210196 Bush, Jr. et al. Oct 2004 A1
20050033234 Sadowski et al. Feb 2005 A1
20050038391 Wittland et al. Feb 2005 A1
20050171512 Flaherty Aug 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060036216 Rimlinger Feb 2006 A1
20060095010 Westbye May 2006 A1
20060124269 Miyazaki et al. Jun 2006 A1
20060184154 Moberg Aug 2006 A1
20060206054 Shekalim Sep 2006 A1
20060229569 Lavi Oct 2006 A1
20060264888 Moberg Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20060293722 Slatkine et al. Dec 2006 A1
20070025879 Vandergaw Feb 2007 A1
20070073228 Mernoe et al. Mar 2007 A1
20070118405 Campbell et al. May 2007 A1
20070167912 Causey et al. Jul 2007 A1
20070179444 Causey et al. Aug 2007 A1
20070185449 Mernoe Aug 2007 A1
20070197954 Keenan Aug 2007 A1
20070203454 Shermer et al. Aug 2007 A1
20080033367 Haury et al. Feb 2008 A1
20080033393 Edwards et al. Feb 2008 A1
20080097326 Moberg Apr 2008 A1
20080097381 Moberg et al. Apr 2008 A1
20080215013 Felix-Faure Sep 2008 A1
20080243087 Enggaard Oct 2008 A1
20080319383 Byland et al. Dec 2008 A1
20090012478 Weston Jan 2009 A1
20090076383 Toews et al. Mar 2009 A1
20090088694 Carter et al. Apr 2009 A1
20090093763 Gonnelli et al. Apr 2009 A1
20090093792 Gross Apr 2009 A1
20090093793 Gross et al. Apr 2009 A1
20090105650 Wiegel Apr 2009 A1
20090105663 Brand Apr 2009 A1
20090143730 De Polo et al. Jun 2009 A1
20090204076 Liversidge Aug 2009 A1
20090299288 Sie et al. Dec 2009 A1
20090299290 Moberg Dec 2009 A1
20090326459 Shipway Dec 2009 A1
20100076382 Weston Mar 2010 A1
20100168683 Cabiri Jul 2010 A1
20110066131 Cabiri Mar 2011 A1
20110092915 Olson Apr 2011 A1
20110112504 Causey et al. May 2011 A1
20110224616 Slate et al. Sep 2011 A1
20120022496 Causey et al. Jan 2012 A1
20120041387 Bruggemann et al. Feb 2012 A1
20120172817 Bruggemann et al. Jul 2012 A1
20120184917 Bom Jul 2012 A1
20130085457 Schiff et al. Apr 2013 A1
20130110049 Cronenberg et al. May 2013 A1
20130190693 Ekman et al. Jul 2013 A1
20130245596 Cabiri Sep 2013 A1
20130267895 Hemmingsen Oct 2013 A1
20130296799 Degtiar Nov 2013 A1
20130304021 Cabiri et al. Nov 2013 A1
20130310753 Cabiri Nov 2013 A1
20130331791 Gross et al. Dec 2013 A1
20140018735 Causey et al. Jan 2014 A1
20140121633 Causey et al. May 2014 A1
20140148784 Anderson et al. May 2014 A1
20140174223 Gross et al. Jun 2014 A1
20140194854 Tsals Jul 2014 A1
20140236087 Alderete, Jr. et al. Aug 2014 A1
20150119798 Gross et al. Apr 2015 A1
20150374926 Gross et al. Dec 2015 A1
20160030665 Cabiri Feb 2016 A1
20160228652 Cabiri Aug 2016 A1
20160296716 Cabiri et al. Oct 2016 A1
20160346478 Bar-El Dec 2016 A1
20190022306 Gibson Jan 2019 A1
Foreign Referenced Citations (38)
Number Date Country
1505535 Jun 2004 CN
101227943 Jul 2008 CN
101448536 Jun 2009 CN
101522235 Sep 2009 CN
101541362 Sep 2009 CN
201692438 Jan 2011 CN
102378638 Mar 2012 CN
1064693 Sep 1959 DE
19717107 Nov 1998 DE
1003581 Nov 2000 EP
1219312 Jul 2002 EP
1530979 May 2005 EP
2770136 Apr 1999 FR
H09-505758 Jun 1997 JP
2002528676 Sep 2002 JP
2009502273 Jan 2009 JP
9307922 Apr 1993 WO
9407553 Apr 1994 WO
9700091 Jan 1997 WO
200130421 May 2001 WO
200172357 Oct 2001 WO
0187384 Nov 2001 WO
200238204 May 2002 WO
02072182 Sep 2002 WO
04000397 Dec 2003 WO
2004105841 Dec 2004 WO
2005072795 Aug 2005 WO
200637434 Apr 2006 WO
06069380 Jun 2006 WO
2006121921 Nov 2006 WO
2007017052 Feb 2007 WO
2007051563 May 2007 WO
20070073228 Jun 2007 WO
2009044401 Apr 2009 WO
2009144085 Dec 2009 WO
2010089313 Aug 2010 WO
2011090956 Jul 2011 WO
2015114158 Aug 2015 WO
Non-Patent Literature Citations (68)
Entry
Office Action dated Feb. 16, 2017 in CN Application No. 2014101783189.
Extended European Search Report dated Nov. 10, 2016 in EP Application No. 08808111.2.
Office Action dated Feb. 24, 2017 in U.S. Appl. No. 13/964,651, by Gross.
Int'l Search Report and Written Opinion dated Jul. 6, 2017 in Int'l Application No. PCT/US2017/022966.
Office Action dated Jul. 3, 2017 in CN Application No. 2014101783742.
Office Action dated May 24, 2017 in U.S. Appl. No. 13/874,121, by Degtiar.
Extended European Search Report dated Jul. 3, 2017 in EP Application No. 16190054.3.
Office Action issued May 4, 2017 in CN Application No. 2014101836665.
Office Action issued Jun. 9, 2017 in EP Application No. 14166596.8.
Office Action dated Jun. 9, 2017 in EP Application No. 14166591.9.
Office Action issued May 1, 2015 in U.S. Appl. No. 14/638,525 by Filman.
Office Action dated Dec. 4, 2017 in CN Application No. 201410178374.2.
Office Action dated Nov. 13, 2017 in U.S. Appl. No. 14/193,692, by Gross.
Office Action dated Mar. 30, 2018 in U.S. Appl. No. 14/850,450 by Gross.
Office Action dated Mar. 1, 2018 in EP Application No. 14166592.7.
Office Action dated Aug. 14, 2017 in CN Application No. 201410178318.9.
Office Action dated Sep. 28, 2017 in IN Application No. 2528/DELNP/2010.
Office Action dated Nov. 8, 2017 in U.S. Appl. No. 13/874,121, by Degtiar.
West Introduces the Daikyo Crystal Zenith RU Prefillable Syringe, Pharmaceutical Online, Jun. 2008, downloaded from webpage: http://www.pharmaceuticalonline.com/article.mvc/west-introduces-prefillable-syringe-system, Download date: Jan. 2009, original posting date: Jun. 2008, 2 pages.
Copaxone®, Innovative Drugs, Teva Pharmaceuticals, downloaded from webpage: http://tevapharm.com/copaxone/, Download date: Jan. 2009, original posting date: unknown, 3 pages.
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Sep. 21, 2010 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Jul. 7, 2014 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Sep. 18, 2015 in U.S. Appl. No. 13/874,085 by Cabiri.
Office Action dated May 25, 2016 in U.S. Appl. No. 14/874,017 by Cabiri.
Office Action dated Jun. 10, 2016 in U.S. Appl. No. 13/964,651 by Gross.
Office Action dated May 31, 2016 in U.S. Appl. No. 14/593,051 by Gross.
Int'l Search Report and Written Opinion dated May 13, 2009 in Int'l Application No. PCT/IL2008/001312.
Int'l Preliminary Report on Patentability dated Apr. 7, 2010 in Int'l Application No. PCT/IL2008/001312.
Office Action dated Sep. 30, 2010 in U.S. Appl. No. 12/689,250, by Cabiri.
Office Action dated May 3, 2012 in CN Application No. 200880117084.X.
Office Action dated Jan. 30, 2013 in CN Application No. 200880117084.X.
Office Action dated Aug. 15, 2013 in CN Application No. 200880117084.X.
Office Action dated Mar. 5, 2014 in CN Application No. 200880117084.X.
Office Action dated Feb. 20, 2015 in U.S. Appl. No. 13/521,181, by Cabiri.
Office Action dated Jul. 31, 2015 in U.S. Appl. No. 13/521,181 by Cabiri.
Extended Search Report dated Feb. 23, 2015 in EP Application No. 14166596.8.
Search Report dated Nov. 24, 2015 in EP Application No. 14166592.7.
Extended Search Report dated Mar. 8, 2016 in EP Application No. 14166592.7.
Extended Search Report dated Feb. 23, 2015 in EP Application No. 14166591.9.
Office Action dated Jan. 8, 2013 in JP Application No. 2010-527595.
Int'l Search Report dated Oct. 12, 2011 in Int'l Application No. PCT/US2011/021605.
Int'l Written Opinion dated Jul. 19, 2012 in Int'l Application No. PCT/US2011/021605.
Int'l Preliminary Report on Patentability dated Feb. 7, 2013 in Int'l Application No. PCT/US2011/021605.
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550069.
Office Action dated Nov. 5, 2013 in JP Application No. 2010-527595.
Office Action dated Jun. 3, 2014 in JP Application No. 2010-527595.
Office Action dated May 7, 2015 in JP Application No. 2012-550069.
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,688 by Gross.
Office Action dated Sep. 2, 2010 in U.S. Appl. No. 12/244,688 by Gross.
Extended Search Report dated Aug. 7, 2014 in EP Application No. 14171477.4.
Office Action dated Aug. 6, 2014 in EP Application No. 11707942.
Office Action dated Feb. 4, 2014 in EP Application No. 11707942.
Office Action dated Dec. 1, 2015 in CN Application No. 2014102892041.
Office Action dated Apr. 22, 2016 in CN Application No. 2014102892041.
Office Action dated May 5, 2015 in CN Application No. 201180006571.0.
Office Action dated Nov. 2, 2014 in CN Application No. 201180006571.0.
Office Action dated Feb. 28, 2014 in CN Application No. 201180006571.0.
Office Action dated Jun. 2, 2016 in CN Application No. 2014101783189.
Search Report dated Oct. 14, 2016 in CN Application No. 2014101783742.
Office Action dated Oct. 28, 2016 in CN Application No. 2014101783742.
Office Action dated Nov. 10, 2016 in U.S. Appl. No. 13/874,121, by Degtiar.
Office Action dated Nov. 25, 2016 in U.S. Appl. No. 13/874,017, by Cabiri.
Office Action dated Oct. 5, 2016 in U.S. Appl. No. 13/964,651, by Gross.
Office Action dated Dec. 9, 2016 in U.S. Appl. No. 14/593,051, by Gross.
Office Action dated Jan. 10, 2017 in U.S. Appl. No. 14/193,692, by Gross.
Office Action dated May 18, 2018 in EP 14166591.9.
Related Publications (1)
Number Date Country
20170112998 A1 Apr 2017 US
Provisional Applications (1)
Number Date Country
60997459 Oct 2007 US
Divisions (1)
Number Date Country
Parent 13874121 Apr 2013 US
Child 15342411 US
Continuation in Parts (1)
Number Date Country
Parent 12244666 Oct 2008 US
Child 13874121 US